Ireland· IE-PA-EU/1/09/558/1-12
Clopidogrel BGR 75 mg film-coated tablets
A clopidogrel product containing clopidogrel, registered in Ireland by Laboratoires BIOGARAN. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Clopidogrel is registered in 18 of 19 countries.
Countries holding a registration under ATC B01AC04 (clopidogrel), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Clopidogrel · ATC B01AC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clopidogrel costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.29 in France to $1.04 in Switzerland — a ×3.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clopidogrel · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.04
- IT Italy$0.48
- FR France$0.29
The record
At a glance
HPRA (Ireland)- Active substance
- Clopidogrel
- Manufacturer
- Laboratoires BIOGARAN
- Country
- Ireland (IE)
- ATC code
- B01AC04
- ATC class
- Clopidogrel
- Defined daily dose
- 75 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/09/558/1-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
779 interactions on record for clopidogrel.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clopidogrel · interactions on record
779 records
- 64 severe
- 162 moderate
- 12 minor
- 480 info
Most severe, free to view
- OmeprazoleA02BC01severe
- RabeprazoleA02BC04severe
- EsomeprazoleA02BC05severe
- LoperamideA07DA03severe
61 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clopidogrel in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLOPIDOGREL ACTAVISActavis Group PTC ehf., Hafnarfjördur
- SpainAGRELAN 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEspecialidades Farmaceuticas Centrum S.A.
- FinlandClopidogrel 1a PharmaAcino Pharma GmbH
- United StatesClopidogrelAmerican Health Packaging
- BelgiumClopidogrel (HCl) Sandoz 75 mgPI Pharma
- PolandAgregexMedezin Sp. z o.o.
- ItalyAVERELIXF.I.R.M.A. S.P.A.
- SwedenClopidogrel Accord 75 mg Filmdragerad tablettAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aclop, Clopidogrel +pharma
- Belgium · Clopidogrel (Hcl) Sandoz, Clopidogrel Ab
- Bulgaria · Глопенел, Егитромб
- Cyprus · Adagrel, Agregex
- Czechia · Clopidogrel Accord, Clopidogrel Actavis
- Germany · Clopidogrel, Clopidogrel 1 A Pharma
- Denmark · Clopidogrel "juta", Clopidogrel Accord
- Estonia · Clopidogrel Sanoswiss, Trombex
- Spain · Clopidogrel Almus, Clopidogrel Alter
- Finland · Clopidogrel, Clopidogrel Orion
- France · Clopidogrel Accord, Clopidogrel Almus Pharma
- United Kingdom (Northern Ireland) · Cadix, Clopidogrel
- Greece · Blodegrel, Carder
- Croatia · Gardin, Klopidex
- Hungary · Clopid, Clopidogrel Actavis
- Iceland · Clopidogrel Actavis, Clopidogrel Krka
- Italy · Averelix, Clopidogrel Almus Pharma
- Liechtenstein · Clopidogrel Ratiopharm, Clopidogrel Teva
- Lithuania · Clopidogrel Actavis, Clopidogrel Sanoswiss
- Luxembourg · Clopidogrel (Hcl) Sandoz, Clopidogrel Eg
- Latvia · Trombex
- Malta · Clopidogrel Aurobindo, Clopidogrel Azure
- Netherlands · Clopidogrel (Als Hydrochloride) Sandoz, Clopidogrel Accord
- Norway · Clopidogrel Accord, Clopidogrel Actavis
- Poland · Agregex, Areplex
- Portugal · Clopidogrel Aba Farmoz - Sociedade Técnico Medicinal, Clopidogrel Adapes
- Romania · Clopidogrel Arena, Clopidogrel Eipico
- Sweden · Clopidogrel Accord, Clopidogrel Actavis
- Slovakia · Clopidogrel Actavis, Clopidogrel Medreg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa169eff-33fa-4b60-ab13-6d20c45fc744 GET /v1/drugs/aa169eff-33fa-4b60-ab13-6d20c45fc744?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"B01AC",
"B01AC04"
],
"strength": null,
"pa_number": "EU/1/09/558/1-12",
"substances": [
"Clopidogrel"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "21/09/2009",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about clopidogrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.